Efficacy of Ascorbic Acid on Reducing the Development of Contrast-Induced Nephropathy
محل انتشار: مجله بین المللی پزشکی رضوی، دوره: 5، شماره: 1
سال انتشار: 1395
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 283
فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_RIJO-5-1_001
تاریخ نمایه سازی: 6 اسفند 1398
چکیده مقاله:
Introduction: To assess the benefits of prophylactic ascorbic acid to reduce development of contrast-induced nephropathy (CIN)in patients undergoing percutaneous coronary interventions (PCIs).Methods: PubMed was searched with the search strategy of (vitamin C OR ascorbic acid) AND (kidney OR renal) AND (PCI OR percutaneouscoronary Intervention OR cardiac OR heart). There was no date and language restriction for the selection of the articles.All the randomized controlled trials (RCTs) which investigated the efficacy of AA on reducing the incidence of CIN were included.Totally 267 articles were found at the initial search; however, only 10 RCTs were eligible to be included. Odds ratio is presented foreach of the articles as the effect size.Conclusions: Controversial findings were reported on the efficacy of AA on reducing the CIN development; due to various limitationsof these articles, there is still great debate among the cardiology and radiology communities, which increases the need forfurther researches.
کلیدواژه ها:
نویسندگان
Hojat Naghavi
Anesthesiologist, Department of Anesthesiology and Critical Care, Mashhad, IR Iran
Shahram Amini
Associate Professor of Anesthesiology and Critical Care, Cardiac Anesthesia Research Center, Mashhad University of Medical Sciences, Mashhad, IR Iran